WhyIs

Why is Spyre Therapeutics, Inc. stock down today?

June 23, 2026

Spyre Therapeutics, Inc.

SYRE · NMS · USD

$99.99
0.33 (0.33%)

vs. prev. close $100.32

Last updated Jun 23, 2026 15:13

Intraday Chart — 5-min intervals

📊
AI Summary

SYRE · less than a minute ago

cached

Spyre Therapeutics, Inc. dips 0.33% — MT Newswires reports

Spyre Therapeutics, Inc. (SYRE) is drifting slightly lower, at $99. 99 — down 0. 33% from yesterday's close of $100. 32. Today's move appears driven by recent headlines, including "Deutsche Bank Adjusts Spyre Therapeutics Price Target to $135 From $115, Maintains Buy Rating" and "Update: Wedbush Raises Price Target on Spyre Therapeutics to $100 From $80 on Positive SPY002 Results, Maintains Outperform Rating". News sentiment around SYRE is leaning positive.

The broader market is under pressure (S&P 500: -1. 1%, Nasdaq: -1. 7%, Dow Jones: +0. 0%, Shanghai: +1. 8%, Hang Seng: -1. 8%). Past performance does not guarantee future results.

Key Factors

1Deutsche Bank Adjusts Spyre Therapeutics Price Target to $135 From $115, Maintains Buy Rating
2📈 Update: Wedbush Raises Price Target on Spyre Therapeutics to $100 From $80 on Positive SPY002 Results, Maintains Outperform Rating
3Wedbush Raises Price Target on Spyre Therapeutics to $100 From $80, Maintains Outperform Rating
4🌐 Broad market: S&P 500: -1.1%, Nasdaq: -1.7%, Dow Jones: +0.0%, Shanghai: +1.8%, Hang Seng: -1.8%

Auto-generated analysis · Not financial advice

less than a minute ago
⚠️ Disclaimer: The information on this page is for informational purposes only and does not constitute financial advice. AI-generated summaries may be inaccurate. Always conduct your own research and consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.
🌐Market ContextRisk-Off 📉

S&P 500

-1.13%

Nasdaq

-1.73%

Dow Jones

+0.01%

Shanghai

+1.78%

Hang Seng

-1.82%

Nikkei 225

-3.55%

FTSE 100

+0.19%

Nifty 50

-1.16%

DAX

-0.74%

OMX Stockholm

-0.82%

Search another stock

🔍